Definitive Contract 75D30119C06016

Award Date 9/30/19
Potential Completion Date 9/29/21
Potential Value $380K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Universidad Del Desarrollo (UDD), a private university in Chile. The $372,060 contract, awarded on September 30, 2018, is for research on multidrug-resistant gram-negative bacteria in low and middle-income countries under Broad Agency Announcement (BAA) 2.1. UDD, which has received prior prime and subcontract awards from the CDC, will perform...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $401,000.00 Firm Fixed Price Definitive Contract to Universidad Del Desarrollo (UDD), a private university in Chile, to support topic 4.4 - DESAROLLO under a fiscal year 2021 Broad Agency Announcement. The contract, which does not have a set-aside designation, was awarded on September 30, 2021 and is scheduled for completion on December 29, 2022. As a prime contractor, UDD has previously received...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $175,707.20 firm fixed-price definitive contract to Universidad De Cantabria, doing business as Ides UC Universidad De Cantabria, for the "FY 21 BAA TOPIC 4.1 - CANTABRIA" effort. The place of performance is Atlanta, Georgia, and the period of performance runs through November 30, 2022. This contract did not have a set-aside designation. The CDC has previously awarded Universidad De...
This is a $550,000.00 firm-fixed-price federal contract awarded by the Centers for Disease Control and Prevention (CDC) to the Universidad Autonoma De Yucatan (UADY), a state-controlled institution of higher learning in Mexico. The contract, which has no set-aside designation, is for aerial ultra-low volume spraying evaluation. UADY has experience conducting research and programming related to public health, infectious diseases, and mosquito control. The contract award indicates UADY's...
This federal contract award, with ID HHSD200201692277C, was issued by the Centers for Disease Control and Prevention (CDC) to the University of Colorado-Denver, doing business as The Regents of the University of Colorado, for the UTIDECIDE program. The $249,708 firm fixed-price definitive contract has an ultimate completion date of September 19, 2017 and was awarded on September 13, 2016. The contract does not have a set-aside designation. The University of Colorado-Denver is a major public...
This is a firm fixed price definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Dalhousie University, a research-intensive educational institution, on September 29, 2023. The contract, which is not set-aside, has a potential value of $2,693,797.00 and a performance period ending on March 31, 2026. The contract was awarded under Broad Agency Announcement (BAA) Topic 36 and will involve Dalhousie University providing...
This is a $4,916,756.12 firm fixed price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Utah Office of Sponsored Projects. The contract is for "2021 DOMAIN 1-A015 MODELING AND NOVEL DATA" work under the CDC's Safety and Healthcare Epidemiology Prevention Research Development 2016 (SHEPheRD 2016) multi-award indefinite delivery/indefinite quantity (IDIQ) contract. The contract has an ultimate completion date of August 31,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Definitive Contract to the University of Chicago, a private university and non-profit organization, to provide "NEW METAGENOMIC TOOLS FOR AR" services. The $227,820.00 Firm Fixed Price contract has a completion date of September 29, 2019. The contract does not have a set-aside designation. The University of Chicago has previously received prime and sub awards from federal agencies like...
This is a $293,359 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Utah for the development and demonstration of mine safety and health technology. The contract has an ultimate completion date of April 4, 2025 and is not set aside for any specific business type. The University of Utah is the prime contractor and has experience executing complex research projects for federal agencies, including the Department of Veterans...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of California, San Diego (UCSD) in the amount of $622,412.00. The contract is for work under Topic 12 of the CDC's Fiscal Year 2023 Broad Agency Announcement (BAA), with a period of performance through August 31, 2025. The contract has a cost-no-fee pricing type and does not use any set-aside designations. UCSD, a major public research university, will be performing the work in La...

This award is a Definitive Contract with a Firm Fixed Price type, valued at $380,250.00, issued by the Centers for Disease Control and Prevention (CDC) to the private university Universidad Del Desarrollo (UDD) located in Chile. The contract was awarded under a Broad Agency Announcement (BAA) and does not have a set-aside designation.

UDD, which provides research, technical, and consulting services to U.S. federal agencies, has received prior prime and subcontract awards from the Department of Health and Human Services and CDC. Under this contract, UDD will likely conduct research related to the CDC's work on disease etiology and antimicrobial resistance. As a subrecipient on grants from Johns Hopkins University and Duke University, UDD has also contributed to observational studies on multidrug-resistant organism infections and treatment approaches.

Generated 6/30/24, 9:12 AM